Eszopiclone Tablets — Class II drug recall D-1174-2022
Terminated recall by Macleods Pharma Usa Inc, reported 2022-07-13, distributed nationwide. Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.
| Recall number | D-1174-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Macleods Pharma Usa Inc, Plainsboro, NJ, United States |
| Recall initiated | 2022-06-16 |
| Classified | 2022-07-05 |
| Reported by FDA | 2022-07-13 |
| Terminated | 2024-03-20 |
| Distributed | Nationwide (US) |
| Quantity | 168,690 tablets |
| NDC | 33342-0299, 33342-0299-07, 33342-0299-11, 33342-0299-12, 33342-0299-44, 33342-0300, 33342-0300-11, 33342-0300-12, 33342-0300-44, 33342-0301, 33342-0301-11, 33342-0301-12, 33342-0301-44 |
| Lot numbers | BEK2009A |
| Expiration dates | 2023-11 |
Product
Eszopiclone Tablets, USP 1 mg, packaged in 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, INDIA, NDC 33342-299-07
Reason for recall
Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1174-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.